These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23329579)

  • 1. The role of type II deiodinase polymorphisms in clinical management of hypothyroid patients treated with levothyroxine.
    Al-azzam SI; Alkhateeb AM; Al-Azzeh O; Alzoubi KH; Khabour OF
    Exp Clin Endocrinol Diabetes; 2013 May; 121(5):300-5. PubMed ID: 23329579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The associations of polymorphisms of TSH receptor and thyroid hormone receptor genes with L-thyroxine treatment in hypothyroid patients.
    Al-Azzam SI; Alzoubi KH; Khabour O; Al-Azzeh O
    Hormones (Athens); 2014; 13(3):389-97. PubMed ID: 25079464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
    Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination L-T3 and L-T4 therapy for hypothyroidism.
    Wartofsky L
    Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):460-6. PubMed ID: 23974776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients.
    Panicker V; Saravanan P; Vaidya B; Evans J; Hattersley AT; Frayling TM; Dayan CM
    J Clin Endocrinol Metab; 2009 May; 94(5):1623-9. PubMed ID: 19190113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological relevance of deiodinase polymorphism.
    Bianco AC; Kim BS
    Curr Opin Endocrinol Diabetes Obes; 2018 Oct; 25(5):341-346. PubMed ID: 30063552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between genetic polymorphism and levothyroxine bioavailability in hypothyroid patients.
    Arici M; Oztas E; Yanar F; Aksakal N; Ozcinar B; Ozhan G
    Endocr J; 2018 Mar; 65(3):317-323. PubMed ID: 29321381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3'-triiodothyronine therapy.
    Appelhof BC; Peeters RP; Wiersinga WM; Visser TJ; Wekking EM; Huyser J; Schene AH; Tijssen JG; Hoogendijk WJ; Fliers E
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6296-9. PubMed ID: 16144953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients.
    Castagna MG; Dentice M; Cantara S; Ambrosio R; Maino F; Porcelli T; Marzocchi C; Garbi C; Pacini F; Salvatore D
    J Clin Endocrinol Metab; 2017 May; 102(5):1623-1630. PubMed ID: 28324063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No Effect of the Thr92Ala Polymorphism of Deiodinase-2 on Thyroid Hormone Parameters, Health-Related Quality of Life, and Cognitive Functioning in a Large Population-Based Cohort Study.
    Wouters HJ; van Loon HC; van der Klauw MM; Elderson MF; Slagter SN; Kobold AM; Kema IP; Links TP; van Vliet-Ostaptchouk JV; Wolffenbuttel BH
    Thyroid; 2017 Feb; 27(2):147-155. PubMed ID: 27786042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis.
    Heemstra KA; Hoftijzer HC; van der Deure WM; Peeters RP; Fliers E; Appelhof BC; Wiersinga WM; Corssmit EP; Visser TJ; Smit JW
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):279-83. PubMed ID: 19018782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between eight adiponectin polymorphisms, obesity, and metabolic syndrome parameters in Tunisian volunteers.
    Boumaiza I; Omezzine A; Rejeb J; Rebhi L; Rejeb NB; Nabli N; Abdelaziz AB; Bouslama A
    Metab Syndr Relat Disord; 2011 Dec; 9(6):419-26. PubMed ID: 21870907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of DIO2 T92A and PPARgamma2 P12A polymorphisms in the modulation of metabolic syndrome.
    Fiorito M; Torrente I; De Cosmo S; Guida V; Colosimo A; Prudente S; Flex E; Menghini R; Miccoli R; Penno G; Pellegrini F; Tassi V; Federici M; Trischitta V; Dallapiccola B
    Obesity (Silver Spring); 2007 Dec; 15(12):2889-95. PubMed ID: 18198294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNP rs11185644 in RXRA gene and SNP rs2235544 in DIO1 gene predict dosage requirements in a cross-sectional sample of hypothyroid patients.
    AlEjielat R; Khaleel A; Batarseh YS; Abu-Qatouseh L; Al-Wawi S; AlSunna T
    BMC Endocr Disord; 2023 Aug; 23(1):167. PubMed ID: 37563580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between DIO2 Thr92Ala polymorphism and hypertension in patients with hypothyroidism: Korean Genome and Epidemiology Study.
    Kang YM; Koo BS; Yi HS; Kim JT; Park B; Lee JH; Shong M; Kang YE
    Korean J Intern Med; 2023 Mar; 38(2):226-237. PubMed ID: 36646987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjustment of L-T4 substitutive therapy in pregnant women with subclinical, overt or post-ablative hypothyroidism.
    Verga U; Bergamaschi S; Cortelazzi D; Ronzoni S; Marconi AM; Beck-Peccoz P
    Clin Endocrinol (Oxf); 2009 May; 70(5):798-802. PubMed ID: 18771569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do we need still more trials on T4 and T3 combination therapy in hypothyroidism?
    Wiersinga WM
    Eur J Endocrinol; 2009 Dec; 161(6):955-9. PubMed ID: 19808902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of 19 functional polymorphisms in iodothyronine deiodinase and psychological well-being in hypothyroid patients.
    Young Cho Y; Jeong Kim H; Won Jang H; Hyuk Kim T; Ki CS; Wook Kim S; Hoon Chung J
    Endocrine; 2017 Jul; 57(1):115-124. PubMed ID: 28466400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism.
    Schmid C; Zwimpfer C; Brändle M; Krayenbühl PA; Zapf J; Wiesli P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):706-11. PubMed ID: 17121519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.